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Abstract Platelet-activating factor is a phospholipid with
several documented roles in the pre-implantation embryo.
Enzymes that belong to the platelet-activating factor acetylhy-
drolases family inactivate platelet-activating factor. Cytosolic
platelet-activating factor acetylhydrolase (Ib) is a heterotetramer
composed of two catalytic subunits (K1/K2) and two regulatory
LIS1 subunits. The expression of these components was
monitored in the mouse oocytes and zygotes using reverse-
transcribed PCR and Western blot analysis. Interestingly, these
proteins are expressed in the oocyte and zygote and their
expression increases after fertilization, probably due to stabiliza-
tion of maternal RNA. Lis1 mRNA transcription also increases
after fertilization. However, assaying for expression of a specific
paternal LIS1 isoform detected no zygotic translation in the one
cell stage. These findings suggest a potential role for platelet-
activating factor acetylhydrolase (Ib) components in the early
mouse embryo.
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1. Introduction
Platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-
phosphocholine; PAF) is a potent phospholipid that is impor-
tant in many biological processes including pre- and post-fer-
tilization (reviewed in [1,2]). PAF increases the sperm motility
and improves the acrosome reaction [3^6]. This phospholipid
is produced by zygotes but not by unfertilized ova [7]. Addi-
tionally, production of PAF is believed to be important for
the development of the embryos. PAF elicits activation of
signal transduction pathways through PAF receptors that
are coupled to guanine nucleotide-binding proteins [8^12].
The presence of the PAF receptor has been documented al-
ready at the two cell stage embryo [13]. Under in vitro culture
conditions, addition of exogenous PAF enhanced the human
and mouse embryo viability [14,15]. PAF was shown to act as
a survival factor during the two cell stage of development,
protecting embryos from subsequent cell death [16]. Most of
the information available regards extracellular secreted PAF.
Within cells, PAF is synthesized by at least two pathways: the
remodeling route and de novo synthesis (reviewed by [17,18]).
It is widely believed that PAF has important intracellular
functions as well [19] and the existence of intracellular PAF-
binding sites shown in rat cerebral cortex cells [20] supports
this notion. However, to date, the pathways in which intra-
cellular PAF functions are not clear.
Deacetylation of PAF by PAF-acetylhydrolase (AH) results
in a biologically inactive molecule, lyso-PAF. This enzymatic
activity is considered to be important during the early devel-
opment of the embryo. A decreased activity of PAF-AH in
follicular £uids was correlated with more successful pregnan-
cies [21]. Relatively low levels of PAF-AH activity were meas-
ured in the mouse uterus during the pre-implantation phase
[22]. A reduced activity is found irrespective of the presence of
the embryo, as similar values were measured from pseudo-
pregnant mice [22].
PAF-AH composes a group of enzymes that are products
of di¡erent genes (reviewed by [23]). The main PAF-AH in the
serum is a 45 kDa monomer. In mammalian brain as well as
in other tissues, three cytoplasmic isoforms were identi¢ed, Ia,
Ib and II, from which only Ib and II were cloned [24^26]. The
Ib and II isoforms di¡er in several aspects, while the Ib iso-
form is a heterotetramer composed of 30 (K2) and 29 (K1)
kDa subunits and two 45 kDa subunits (L, LIS1), the II iso-
form is a 40 kDa monomer [27]. The Ib isoform is expressed
at the highest levels in bovine brain, while isoform II is ex-
pressed most abundantly in bovine liver and kidney. The de-
duced amino acid sequence of isoform II has no homology
with any subunit of isoform Ib, but showed 41% identity with
that of plasma PAF-AH [27]. The focus of our study is iso-
form Ib, which is composed of two highly homologous K
subunits forming a catalytic dimer and two regulatory L sub-
units. The L subunit is the product of the LIS1 gene [28],
which, when mutated in humans, results in abnormal brain
patterning known as lissencephaly. We have demonstrated an
additional role for LIS1 in its interaction with tubulin, a
component of the cytoskeleton [29]. Addition of LIS1 modu-
lates microtubule dynamics in vitro [29]. Recent gene targeting
of Lis1 demonstrated that the homozygotes are early lethal
([30] and A.C. unpublished results). In view of the importance
of PAF and of LIS1 during early developmental processes, we
set out to investigate the activity of PAF-AH and the expres-
sion of PAF-AH(Ib) subunits in mouse oocytes and zygotes.
2. Materials and methods
2.1. Animals
MF1 mice were housed under a 12 h light/12 h dark cycle and had
access to food and water ad libitum. Superovulation and synchroni-
zation of 4 week old females was achieved by intraperitoneal injection
of 5 IU of pregnant mare serum followed by injection of 5 IU of
human chorionic gonadotropin (hCG) after 46 h. To achieve timed
pregnancies, females were mated overnight and the presence of vagi-
nal plugs was examined (0.5 days post-coitum). Generation of Lis1 3/
+ (heterozygote knockout) mice will be described elsewhere (Cahana
et al., manuscript in preparation). Brie£y, the ¢rst encoding exon of
Lis1 was £anked by two loxP sites. Heterozygote mice were crossed
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with PGK-Cre mice on an MF1 background [31], resulting in the
removal of the ¢rst encoding exon. The mutated allele gave rise to
a shorter protein due to internal initiation.
2.2. Oocytes and zygotes collection
In the morning following hCG injection, females (mated or not)
were killed and oviducts were dissected and placed in M2 medium
(as described in [32]). The oocytes or zygotes were then released from
the swollen ampulla. The oocytes or zygotes were separated from the
associated cumulus cells by incubation for a few minutes in 300 mg/ml
hyaluronidase (Sigma H 3884). Immediately after the dissociation of
cumulus cells, the oocytes or zygotes were washed twice in M2 me-
dium and collected.
2.3. Isolation of total RNA and reverse-transcribed (RT)-PCR
Total RNA from 400 oocytes or zygotes per batch was extracted
with Tri-reagent (TR 118, Molecular Research Center, OH, USA),
after addition of 10 Wl glycogen as a carrier. Oligonucleotide primers
were designed for Lis1 RT-PCR that will yield a 240 bp product: 5P-
GATGACAAGACCCTCCGTGT-3P ; 5P-GAGCTCAAATGGGGT-
AACCA-3P. For PAF-AH K1, primers for RT-PCR that will yield a
293 bp product: 5P-ACACAGCATGTACTCTGGCG-3P 5P-GCATC-
TAAGAAGTGGGCTCG-3P and for PAF-AH K2, primers for RT-
PCR that will yield a 127 bp product: 5P-AGAATGCCAAGGTGA-
ACCAG-3P ; 5P-AAATCAAACATGTCGTGGCA-3P. Primers were
designed to be from separate exons yielding a speci¢c RT product.
Reverse transcription and ampli¢cation were performed using the
access RT-PCR system (Promega, Madison, WI, USA), according to
the manufacturer’s recommendations. PCR ampli¢cation was carried
out during 40 cycles of denaturing, annealing and extension steps for
30 s at 94‡C, 1 min at 55‡C and 1 min at 68‡C, with a ¢nal extension
step for 10 min at 68‡C. A negative control was made without reverse
transcriptase in the reaction mixture. RT-PCR fragments were ana-
lyzed by electrophoresis on TAE agarose gels.
Quantitation of RT-PCR was done by using IMAGE MASTER
VDS-CL (Dinco and Rhenium Marketing, Jerusalem, Israel) or by
MacBASV2.5, the results using either quantitation methods were sim-
ilar.
Statistical analysis of RT-PCR products was done using one factor
ANOVA-repeated measures.
2.4. Protein extraction
Proteins were extracted in a minimal volume of PBS supplemented
with protease inhibitors (1 mM PMSF, 1 Wg/ml pepstatin A, 10 Wg/ml
leupeptin, 10 Wg/ml aprotinin) and phosphatase inhibitors (10 mM
tetra-sodium diphosphate decahydrate and 50 mM sodium £uoride).
The samples were freeze-thawed and vortexed three times, followed by
15 min centrifugation in an Eppendorf centrifuge at 14 000 rpm. The
supernatant was frozen in aliquots.
2.5. Western blots
Proteins were separated using 12.5% SDS-PAGE gels run at 100
mV for 90 min. Proteins were transferred onto nitrocellulose (Bio-
Trace NT, GelmanSciences) for 45 min at 90 mV. The e⁄ciency of
transfer was determined by Ponceau red stain (Ponceau S concentrate,
Sigma). The ¢lters were then blocked with 5% lyophilized milk in PBS
for 60 min. First antibodies were added (polyclonal anti-K1/K2 [33],
1:300 dilution or monoclonal anti-LIS1 clone 210 [29], 1:1000 dilu-
tion) for 60 min at room temperature. The ¢lters were washed three
times with PBS and 0.05% Tween 20 and then incubated with a
second antibody (goat anti-mouse HRP 1:10 000) for 1 h. The ¢lters
were then washed with PBS and 0.05% Tween 20. The chemilumines-
cence reaction was developed using SuperSignal substrate (Pierce,
USA) according to the manufacturer’s instructions. The autoradio-
grams were analyzed by a densitometer.
3. Results and discussion
The presence of PAF-AH(Ib) subunits in oocytes and zy-
gotes was investigated using RT-PCR. We were able to detect
RNA expression of all three PAF-AH(Ib) subunits (Fig. 1).
While it is known that the oocyte genome is transcriptionally
very active, the majority of the maternal mRNA synthesized is
translationally silent or masked [34]. Therefore, the existence
of mRNA does not necessarily correspond to protein expres-
sion. Western blot analysis (Fig. 2A,C) revealed that LIS1 and
the catalytic subunits are expressed both in the oocyte and in
the zygote. As our antibodies react with both the Kl and K2
subunits and the RT-PCR revealed expression of the tran-
scripts of both subunits, we suggest that both subunits are
expressed also at the protein level. Interestingly, the expres-
sion of LIS1 and of the catalytic subunits increase after fer-
tilization 40% and 50%, respectively (Fig. 2B,D). The increase
is not contributed by the sperm, as Western blot analysis of 10
Wg of sperm protein revealed a very weak signal (data not
shown). Our study demonstrates for the ¢rst time the presence
of PAF-AH(Ib) subunits in mammalian eggs. Oocytes are
known to contain a large store of dormant mRNAs that
may serve as a source of genetic information during early
development. These maternal transcripts are translated selec-
tively during early development. One of the most common
mechanisms of selective maternal mRNA translation is cyto-
plasmic polyadenylation. A class of mRNAs that have rela-
tively short poly(A) tails undergo poly(A) extension in a mes-
sage-speci¢c manner that results in translational activation
(reviewed by [35]). The cis elements necessary for cytoplasmic
poly(A) elongation, at least in vertebrates, are located in the
3P-untranslated regions of mRNAs. These elements include
the hexanucleotide AAUAAA (reviewed in [36^38]) and usu-
ally a cytoplasmic polyadenylation element [39^43]. A prelimi-
nary speci¢c RT-PCR poly(A) reaction (described by [43])
suggests that the Lis1 transcript is indeed polyadenylated in
the zygote (data not shown). We then examined whether there
is any zygotic transcription. We performed a semi-quantitative
RT-PCR from 10 oocytes or zygotes and quanti¢ed products
from cycles that were within the linear range of the reaction
(cycles 19^24) (Fig. 3). Quantitation of the Lis1 mRNA prod-
uct demonstrates that it is double (95% more, P = 0.02) in the
zygotes versus the oocytes. Therefore, we concluded that Lis1
mRNA is transcribed in the fertilized embryo. It has been
demonstrated that the fertilized mouse eggs can delay expres-
sion of zygotic genes by uncoupling the translation from tran-
scription (reviewed in [44]). In order to investigate the possi-
bility of translation of the zygotic transcript, we utilized Lis1
3/+ mice (gene targeting in the Lis1 locus, A.C. manuscript in
preparation). The mutated allele of these mice translates a
shorter LIS1 protein (Fig. 4, right panel, two LIS1 proteins
that di¡er in size are visible in a brain extract). This allows us
to di¡erentiate between the products of two alleles. The exist-
Fig. 1. PAF-AH(Ib) subunits RNA expression. RT-PCR demon-
strates the presence of transcripts of Lis1, K1 and K2 in both oo-
cytes (O) and zygotes (Z). The size of cDNA products from the
three pairs of primers corresponded to the expected sizes and are in-
dicated Lis1: 240 bp, K1: 293 bp, K2: 127 bp. Total RNAs from
100 oocytes or zygotes were used per reaction. The primers designed
from di¡erent exons allow to di¡erentiate between ampli¢cation
from cDNA and DNA.
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ence of speci¢c maternal or paternal isoforms has been used
to study zygotic expression of glucose-phosphate isomerase
[45,46]. We used normal female mice with their maternal
LIS1 protein of the normal size and crossed them to Lis1
(3/+) heterozygote males that carry both a mutated and a
normal allele. Half of the o¡springs are expected to be heter-
ozygote, when the mutant allele is totally of paternal origin.
Therefore, we expected that if there is zygotic LIS1 translation
in the one cell stage, it might be possible to detect a slower
migrating band. As seen in Fig. 4 (left panel), no additional
bands are visible. Therefore, zygotic translation of Lis1
mRNA is most likely delayed until the two cell stage, as has
been previously detailed in other experiments (reviewed in
[44]). The sensitive luciferase transgene marker was found to
be expressed in the one cell stage [47,48]. However, only a
small portion of the resulting fertilized eggs produced lucifer-
ase activity and the level of activity was only 2% of that
observed in two cell embryos [47,48]. A detailed quantitative
analysis of protein synthesis in the early mouse embryo re-
vealed a limited number of coordinately regulated protein sets
that are responsible for most of the changes observed during
the one and two cell stages [49]. Overall, our data demonstrate
maternal expression followed by an increase in the protein
components of PAF-AH(Ib) in the one cell stage, suggesting
a potential function for these proteins in the early embryo. We
can speculate about the putative roles of these proteins in the
one cell stage. One possibility may be related to the enzyme.
PAF is an autocrine factor in the one cell stage (reviewed in
[2]) and perhaps intracellular enzymatic activity in the embryo
is of importance. A second possibility may be related to LIS1-
tubulin interaction. A homolog of LIS1 in Aspergillus nidulans
NudF has a vital function in nuclear migration [50]. LIS1 is a
highly conserved protein (reviewed in [51]), it may retain a
conserved nuclear migration function and therefore may par-
ticipate in pronuclear migration that is one of the essential
processes following fertilization. Further analysis may allow
us to dissect the relative importance of each of these roles.
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